These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36958169)

  • 1. Clinical manifestations, characteristics, and outcome of infections caused by vancomycin-resistant enterococci at a tertiary care center in Lebanon: A case-case-control study.
    Abi Frem J; Ghanem M; Doumat G; Kanafani ZA
    J Infect Public Health; 2023 May; 16(5):741-745. PubMed ID: 36958169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia.
    Cheah AL; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
    BMC Infect Dis; 2014 Jun; 14():353. PubMed ID: 24973797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients.
    Papadimitriou-Olivgeris M; Drougka E; Fligou F; Kolonitsiou F; Liakopoulos A; Dodou V; Anastassiou ED; Petinaki E; Marangos M; Filos KS; Spiliopoulou I
    Infection; 2014 Dec; 42(6):1013-22. PubMed ID: 25143193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of morbidity and mortality after bloodstream infection with vancomycin-resistant versus -susceptible
    Bager P; Kähler J; Andersson M; Holzknecht BJ; Kjær Hansen SG; Schønning K; Nielsen KL; Koch K; Pinholt M; Voldstedlund M; Larsen AR; Kristensen B; Mølbak K; Sönksen UW; Skovgaard S; Skov R; Hammerum AM
    Emerg Microbes Infect; 2024 Dec; 13(1):2309969. PubMed ID: 38258968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.
    Bhavnani SM; Drake JA; Forrest A; Deinhart JA; Jones RN; Biedenbach DJ; Ballow CH
    Diagn Microbiol Infect Dis; 2000 Mar; 36(3):145-58. PubMed ID: 10729656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
    Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
    Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for development of vancomycin-resistant enterococcal bacteremia among VRE colonizers : A retrospective case control study.
    Kaya A; Kaya SY; Balkan II; Bayramlar OF; Mete B; Saltoglu N; Aygün G; Tabak ÖF
    Wien Klin Wochenschr; 2021 May; 133(9-10):478-483. PubMed ID: 32910333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation.
    Vydra J; Shanley RM; George I; Ustun C; Smith AR; Weisdorf DJ; Young JA
    Clin Infect Dis; 2012 Sep; 55(6):764-70. PubMed ID: 22693346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic burden of nosocomial infections caused by vancomycin-resistant enterococci.
    Puchter L; Chaberny IF; Schwab F; Vonberg RP; Bange FC; Ebadi E
    Antimicrob Resist Infect Control; 2018; 7():1. PubMed ID: 29312658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Risk Factors, Costs, and Survival Analysis of Invasive VRE Infections at a Medical Center in Eastern Taiwan.
    Jiang HL; Zhou Z; Wang LS; Fang Y; Li YH; Chu CI
    Int J Infect Dis; 2017 Jan; 54():18-24. PubMed ID: 27836794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin resistance has no influence on outcomes of enterococcal bacteriuria.
    Khair HN; VanTassell P; Henderson JP; Warren DK; Marschall J;
    J Hosp Infect; 2013 Nov; 85(3):183-8. PubMed ID: 23998947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A Systematic Review and Meta-analysis.
    Prematunge C; MacDougall C; Johnstone J; Adomako K; Lam F; Robertson J; Garber G
    Infect Control Hosp Epidemiol; 2016 Jan; 37(1):26-35. PubMed ID: 26434609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bloodstream infections with vancomycin-resistant enterococci are associated with a decreased survival in patients with hematological diseases.
    Weber S; Hogardt M; Reinheimer C; Wichelhaus TA; Kempf VAJ; Kessel J; Wolf S; Serve H; Steffen B; Scheich S
    Ann Hematol; 2019 Mar; 98(3):763-773. PubMed ID: 30666433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First Report of the Local Spread of Vancomycin-Resistant Enterococci Ascribed to the Interspecies Transmission of a
    Hashimoto Y; Kita I; Suzuki M; Hirakawa H; Ohtaki H; Tomita H
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32269153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin-resistant enterococcus in end-stage renal disease.
    Brady JP; Snyder JW; Hasbargen JA
    Am J Kidney Dis; 1998 Sep; 32(3):415-8. PubMed ID: 9740157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.
    Peel T; Cheng AC; Spelman T; Huysmans M; Spelman D
    Clin Microbiol Infect; 2012 Apr; 18(4):388-94. PubMed ID: 21848977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors of vancomycin-resistant enterococcus colonization in burn unit patients.
    Altoparlak U; Koca O; Ozkurt Z; Akcay MN
    Burns; 2011 Feb; 37(1):49-53. PubMed ID: 20926196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci.
    Chavers LS; Moser SA; Funkhouser E; Benjamin WH; Chavers P; Stamm AM; Waites KB
    Microb Drug Resist; 2003; 9 Suppl 1():S69-77. PubMed ID: 14633370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Update to Enterococcal Bacteremia: Epidemiology, Resistance, and Outcome.
    Jafari S; Abdollahi A; Sabahi M; Salehi M; Asadollahi-Amin A; Hasannezhad M; Seifi A
    Infect Disord Drug Targets; 2022; 22(2):e170322187568. PubMed ID: 33155917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.